CD98 regulates vascular smooth muscle cell proliferation in atherosclerosis. (January 2017)

• Record Type: Journal Article
• Authors: Baumer, Yvonne; McCurdy, Sara; Alcala, Martin; Mehta, Nehal; Lee, Bog-Hieu; Ginsberg, Mark H.; Boisvert, William A.
• Is Part Of: Atherosclerosis. Volume 256(2017)
• Page Start: 105
• Page End: 114
• Publication Date: 2017-01
• Subjects: Vascular smooth muscle cell -- CD98 -- Cell proliferation -- Apoptosis -- Atherosclerosis; Arteriosclerosis -- Periodicals; Electronic journals; 616.136
• DOI: 10.1016/j.atherosclerosis.2016.11.017
• Languages: English
• ISSNs: 0021-9150

Abstract

Abstract: Background and aims: Vascular smooth muscle cells (VSMC) migrate and proliferate to form a stabilizing fibrous cap that encapsulates atherosclerotic plaques. CD98 is a transmembrane protein made of two subunits, CD98 heavy chain (CD98hc) and one of six light chains, and is known to be involved in cell proliferation and survival. Because the influence of CD98hc on atherosclerosis development is unknown, our aim was to determine if CD98hc expressed on VSMC plays a role in shaping the morphology of atherosclerotic plaques by regulating VSMC function. Methods: In addition to determining the role of CD98hc in VSMC proliferation and apoptosis, we utilized mice with SMC-specific deletion of CD98hc ( CD98hc fl/fl SM22αCre + ) to determine the effects of CD98hc deficiency on VSMC function in atherosclerotic plaque. Results: After culturing for 5 days in vitro, CD98hc −/− VSMC displayed dramatically reduced cell counts, reduced proliferation, as well as reduced migration compared to control VSMC. Analysis of aortic VSCM after 8 weeks of HFD showed a reduction in CD98hc −/− VSMC proliferation as well as increased apoptosis compared to controls. A long-term atherosclerosis study using SMC-CD98hc −/− /ldlr −/− mice was performed. Although total plaque area was unchanged, CD98hc −/− mice showed reduced presence of VSMC within the plaque (2.1 ± 0.4% vs. 4.3 ± 0.4% SM22α-positive area per plaque area, p < 0.05), decreased collagen content, as well as increased necrotic core area (25.8 ± 1.9% vs. 10.9 ± 1.6%, p < 0.05) compared to control ldlr −/− mice. Conclusions: We conclude that CD98hc is required for VSMC proliferation, and that its deficiency leads to significantly reduced presence of VSMC in the neointima. Thus, CD98hc expression in VSMC contributes to the formation of plaques that are morphologically more stable, and thereby protects against atherothrombosis. Highlights: CD98 deficiency severely limits vascular smooth muscle cell proliferation. Atherosclerotic mice lacking CD98 in their smooth muscle cells have reduced vascular smooth muscle cells in their plaque. Plaques from CD98-deficient mice have significantly larger necrotic core. Breaks in elastin layer of atherosclerotic plaques are reduced in CD98 deficiency. CD98 may play an important role in plaque stability.